200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 13027-88-8
13027-88-8 | Propanamide, 2-hydroxy-2-methyl-
CAS No: 13027-88-8 Catalog No: AG000U7K MDL No:MFCD08063365
Product Description
Catalog Number:
AG000U7K
Chemical Name:
Propanamide, 2-hydroxy-2-methyl-
CAS Number:
13027-88-8
Molecular Formula:
C4H9NO2
Molecular Weight:
103.1198
MDL Number:
MFCD08063365
IUPAC Name:
2-hydroxy-2-methylpropanamide
InChI:
InChI=1S/C4H9NO2/c1-4(2,7)3(5)6/h7H,1-2H3,(H2,5,6)
InChI Key:
DRYMMXUBDRJPDS-UHFFFAOYSA-N
SMILES:
NC(=O)C(O)(C)C
EC Number:
235-890-1
Properties
Complexity:
87.7
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
103.063g/mol
Formal Charge:
0
Heavy Atom Count:
7
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
103.121g/mol
Monoisotopic Mass:
103.063g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
63.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.9
Literature
| Title | Journal |
|---|---|
| Bacterial acyl-CoA mutase specifically catalyzes coenzyme B12-dependent isomerization of 2-hydroxyisobutyryl-CoA and (S)-3-hydroxybutyryl-CoA. | The Journal of biological chemistry 20120504 |
| Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum. | HIV medicine 20081101 |
| Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children. | BMC infectious diseases 20060101 |
| Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1. | The Pediatric infectious disease journal 20030101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.